Last reviewed · How we verify
NCT05130775
Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography
trial testing Transesophageal echocardiograpgy in Tricuspid Regurgitation. Withdrawn.
5 August 2022
Quick facts
| Lead sponsor | Tufts Medical Center |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 5 August 2022 |
| Primary completion | 5 August 2022 |
| Estimated completion | 5 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Transesophageal echocardiograpgy
Conditions studied
- Tricuspid Regurgitation — all drugs for Tricuspid Regurgitation →
Sponsor
Tufts Medical Center
Who can join
18 and older, any sex, with Tricuspid Regurgitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective observational chart review. The aim of the study is to evaluate tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for tricuspid regurgitation severity in comparison to VCA.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Added value of 3D echocardiography in the diagnosis and prognostication of patients with right ventricular dysfunction.
Randazzo M, Maffessanti F, Kotta A, Grapsa J, et al · · 2023 · cited 4× · PMID 38179507 · DOI 10.3389/fcvm.2023.1263864
Verify or expand the search:
- PubMed search for NCT05130775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tricuspid Regurgitation
Currently open trials in the same condition.
- NCT07509658 — TriClip Japan Post-Approval Study · recruiting
- NCT07042360 — Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation · recruiting
- NCT06833476 — TTVR STRONG Under Coverage With Evidence Development (CED) Study · recruiting
- NCT06836011 — A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, a · recruiting
- NCT07085650 — The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation · recruiting
Other Tufts Medical Center trials
Trials by the same sponsor.
- NCT07386041 — Lung Ultrasound-Guided Respiratory Management in Infants · NA · not yet recruiting
- NCT06016517 — Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis · not yet recruiting
- NCT07473713 — Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia · Phase 1 · recruiting
- NCT07097168 — Using WHOOP Fitness Band to Measure Heart Health Variability Before and After Surgery · withdrawn
- NCT06384898 — Remote Tai Chi for Knee Osteoarthritis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05130775 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tufts Medical Center
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05130775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing